Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06725511 · ClinicalTrials.gov registry record · NA

Wellness Program Outreach and Effectiveness

A NA study of Metabolic Syndrome, sponsored by Massachusetts Institute of Technology.

Recruiting
Registry status
NA
Development phase
2,000
Enrollment target
1
Study location

NCT06725511 is a NA study of Metabolic Syndrome that is actively recruiting participants, run by Massachusetts Institute of Technology. The registered enrollment target is 2,000 participants, above the 1,185-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (69% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06725511, a NA study of Metabolic Syndrome, is actively recruiting participants, sponsored by Massachusetts Institute of Technology.

RECRUITING
Registry status
NA
Development phase
2,000 participants
Enrollment target
1
Study location

Study Summary

The investigators will conduct a randomized controlled trial to evaluate the impact of an outreach campaign designed to increase engagement with Pack Health, a Quest Diagnostics wellness program providing individual health coaching for weight management and diabetes prevention. While employee wellness and disease-management programs have the potential to improve wellbeing and reduce healthcare costs, their effectiveness is often undermined by low engagement and selection bias in participant comparisons. This study will test whether an outreach approach that auto-enrolls eligible individuals-employees and their spouses/domestic partners-into the program, with the option to opt out, can increase engagement and improve health outcomes compared to the standard invitation-based approach.

Conditions Studied

Interventions

  • BEHAVIORAL Opt-out framing
  • BEHAVIORAL Opt-in framing

Study Locations (1)

New Jersey

  • Quest Diagnostics - Secaucus

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2024-10-02
Est. Completion 2026-08-31
Phase NA

What the Registry Record Tells You About NCT06725511

The ClinicalTrials.gov registry entry for NCT06725511 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,185-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (69% higher). The listed sponsor is Massachusetts Institute of Technology, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Metabolic Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Opt-out framing is the first listed.

NCT06725511 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06725511 about?

NCT06725511 is a clinical study titled "Wellness Program Outreach and Effectiveness". The investigators will conduct a randomized controlled trial to evaluate the impact of an outreach campaign designed to increase engagement with Pack Health, a Quest Diagnostics wellness program providing individual health coaching for weight management and diabetes prevention. While employee wellne...

What is the current status of trial NCT06725511?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2024-10-02. Estimated completion is 2026-08-31.

What conditions does trial NCT06725511 study?

This clinical trial studies the following conditions: Metabolic Syndrome.

What interventions are being tested in trial NCT06725511?

The interventions under investigation include: Opt-out framing (BEHAVIORAL), Opt-in framing (BEHAVIORAL).

Who is sponsoring clinical trial NCT06725511?

This trial is sponsored by Massachusetts Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06725511 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.